Li-Kwan Chang
-
- Invertebrate Immune Response Mechanisms 2
-
- Viral-associated cancers and disorders 12
-
- Ubiquitin and proteasome pathways 6
- Glycosylation and Glycoproteins Research 2
-
- Eosinophilic Disorders and Syndromes 5
-
- Lymphoma Diagnosis and Treatment 4
-
- Microbial Natural Products and Biosynthesis 3
-
- Parvovirus B19 Infection Studies 3
Li-Kwan Chang
30 papers receiving 709 citations
Peers
Comparison fields: 5 of 79
- Complementary and alternative medicine 60
- Immunology 141
- Oncology 178
- Cancer Research 80
- Molecular Biology 350
Countries citing papers authored by Li-Kwan Chang
This map shows the geographic impact of Li-Kwan Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li-Kwan Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li-Kwan Chang more than expected).
Fields of papers citing papers by Li-Kwan Chang
This network shows the impact of papers produced by Li-Kwan Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li-Kwan Chang. The network helps show where Li-Kwan Chang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li-Kwan Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 3 | |
| 3 | 2020 | 3 | |
| 4 | 2020 | 3 | |
| 5 | 2019 | 8 | |
| 6 | 2017 | 16 | |
| 7 | 2017 | 15 | |
| 8 | 2014 | 10 | |
| 9 | 2013 | 9 | |
| 10 | 2010 | 7 | |
| 11 | 2010 | 21 | |
| 12 | 2008 | 37 | |
| 13 | 2006 | 24 | |
| 14 | 2006 | 56 | |
| 15 | 2005 | 20 | |
| 16 | 2005 | 24 | |
| 17 | 2005 | 19 | |
| 18 | 2004 | 35 | |
| 19 | 1995 | 29 | |
| 20 | 1988 | 122 |
About Li-Kwan Chang
Li-Kwan Chang is a scholar working on Oncology, Rheumatology and Immunology, having authored 30 papers that have together received 722 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (12 papers), Ubiquitin and proteasome pathways (6 papers), Eosinophilic Disorders and Syndromes (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Microbial Natural Products and Biosynthesis (3 papers), Parvovirus B19 Infection Studies (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Invertebrate Immune Response Mechanisms (2 papers). The work is most often cited by research in Complementary and alternative medicine (60 citations), Immunology (141 citations) and Oncology (178 citations). Li-Kwan Chang has collaborated with scholars based in Taiwan, Luxembourg and Hungary. Frequent co-authors include Shih‐Tung Liu, Tsuey-Pin Lin, Vikas P. Sukhatme, Loren Joseph, Shih‐Ying Chen, Wen‐Hung Wang, Chyi‐Liang Chen, Ya‐Fang Chiu, Johannes Scheng-Ming Tschen and Pin‐Der Duh. Their work appears in journals such as Journal of Clinical Investigation, PLoS ONE and Journal of Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.